Hologic Stays Neutral
Recently, we reiterated our Neutral recommendation on Hologic (NASDAQ:HOLX) with a target price of $16.00. During the third quarter of fiscal 2011, Hologic reported an adjusted EPS of 32 cents, in line with the Zacks Consensus Estimate and 2 cents above the year-ago quarter. Revenues were $451.1 million, an increase of 7.2% compared to the [...]
Recently, we reiterated our Neutral recommendation on Hologic (NASDAQ:HOLX) with a target price of $16.00.
During the third quarter of fiscal 2011, Hologic reported an adjusted EPS of 32 cents, in line with the Zacks Consensus Estimate and 2 cents above the year-ago quarter. Revenues were $451.1 million, an increase of 7.2% compared to the prior-year quarter and higher than the Zacks Consensus Estimate of $447 million.
Hologic’s four segments – Breast Health, Diagnostics, Gyn Surgical and … [visit site to read more] or compare Best Credit Cards and Balance Transfer Credit Cards